Aug 25 (Reuters) - U.S. Justice Department is preparing to charge Teva Pharmaceutical Industries Ltd with conspiring with competitors to raise prices for generic drugs, Bloomberg Law reported on Tuesday citing a person familiar with the matter.
The decision follows Teva's refusal to agree for a settlement that would have required paying a criminal penalty and admitting wrongdoing, the report said. (bit.ly/32qtltO)
The company declined to comment on the report. (Reporting By Mrinalika Roy in Bengaluru; Editing by Vinay Dwivedi)
Our Standards: The Thomson Reuters Trust Principles.